Gritstone bio, Inc. Profile Avatar - Palmy Investing

Gritstone bio, Inc.

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid t…

Biotechnology
US, EmeryVille [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of GRTS's Analysis
CIK: 1656634 CUSIP: 39868T105 ISIN: US39868T1051 LEI: - UEI: -
Secondary Listings
GRTS has no secondary listings inside our databases.